Evolent Health Inc - Ordinary Shares - Class A
EVH
Get informed when a big investor buys or sells
+ FollowMarket Cap$517.41M
Close$
$9.64
126.4% upside
Current Fair Value
126.4% upsideUndervalued by 126.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $517.41 Million |
|---|---|
| Enterprise Value | $406.88 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-5.07 |
| Beta | 0.78 |
| Outstanding Shares | 112,542,000 |
Return
| Return on Equity | -133.36% |
|---|---|
| Return on Assets | -25.92% |
| Return on Invested Capital | -34.19% |
Valuation & Multiples
| P/E Ratio | -1.02 |
|---|---|
| PEG | 2.3 |
| Price to Sales | 0.3 |
| Price to Book Ratio | 1.42 |
| Enterprise Value to Revenue | 0.25 |
| Enterprise Value to EBIT | -0.8 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.01
Average shareholder expectationRevenue Estimate
$597.69 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$0.06
Average shareholder expectationRevenue Estimate
$728.57 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.3363▼ 15.47% |
|---|---|
| Total Calls | 179,300▲ 89.33% |
| Total Puts | 239,600▲ 69.69% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 102.27%▲ 3.27% |
|---|---|
| Total Invested | $621.46M▲ 145.85% |
| Investors Holding | 207▲ 10.00% |
ESG Score
No data
About Evolent Health Inc
CEO: Frank Williams